Home Evaluating exercise challenge to validate cardiac autonomic dysfunction in lean PCOS phenotype
Article
Licensed
Unlicensed Requires Authentication

Evaluating exercise challenge to validate cardiac autonomic dysfunction in lean PCOS phenotype

  • Abha Mishra , Renuka Sharma EMAIL logo , Pratima Mittal , Raj Kapoor and Shival Srivastav
Published/Copyright: May 16, 2019

Abstract

Background

Polycystic ovary syndrome (PCOS) is frequently associated with infertility, obesity, hypertension, and diabetes mellitus. Cardiac autonomic dysfunction is well documented in long-term patients of PCOS, with impairment being proportionate to disease duration. However, there is paucity of literature on cardiac autonomic tone in the “lean” phenotype of PCOS. We used exercise challenge to probe for autonomic dysfunction, as assessed by heart rate variability (HRV), an index of cardiac autonomic tone.

Methods

Our study population consisted of 27 newly diagnosed PCOS patients and 25 healthy females matched by age and body mass index. Short-term HRV was assessed using time and frequency domain indices. Moderate, isotonic exercise was used as an interventional tool. Indices of both groups were compared in three bins – at baseline, immediate, and late postexercise stages.

Results

The groups had comparable HRV indices at baseline. However, low-frequency (LF) power was significantly reduced in PCOS patients during immediate and late postexercise phases when compared with controls (p = 0.03 and 0.03, respectively). Time domain indices also exhibited a fall postexercise, although not statistically significant.

Conclusions

Although “lean” phenotype PCOS patients had comparable HRV parameters as controls at baseline, the administration of exercise challenge led to reduced sympathetic drive, evident by reduced LF power in patient group. This may be due to latent autonomic dysfunction in “lean” PCOS, which is unmasked on exposure to exercise challenge. We propose that the evaluation of HRV response to exercise may serve as a sensitive screening tool to detect early cardiovascular dysfunction in newly diagnosed lean PCOS patients.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The authors state no potential conflict of interest.

  6. Informed consent: Informed consent was obtained from all individuals included in this study.

  7. Ethical approval: The research related to human use has been complied with all the relevant national regulations and institutional policies and in accordance the tenets of the Declaration of Helsinki, and it has been approved by the authors’ institutional review board or equivalent committee.

References

[1] Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab 2013;17:138–45.10.4103/2230-8210.107858Search in Google Scholar PubMed PubMed Central

[2] Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011;24:223–7.10.1016/j.jpag.2011.03.002Search in Google Scholar PubMed

[3] Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999;84:1897–9.10.1210/jcem.84.6.5803Search in Google Scholar PubMed

[4] Hallajzadeh J, Khoramdad M, Karamzad N, Almasi-Hashiani A, Janati A, Ayubi E, et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res 2018;10:56–69.10.15171/jcvtr.2018.10Search in Google Scholar PubMed PubMed Central

[5] Tekin G, Tekin A, Kiliçarslan EB, Haydardedeoğlu B, Katircibaşi T, Koçum T, et al. Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome. Int J Cardiol 2008;130:49–55.10.1016/j.ijcard.2007.08.037Search in Google Scholar PubMed

[6] Yildirir A, Aybar F, Kabakci G, Yarali H, Oto A. Heart rate variability in young women with polycystic ovary syndrome. Ann Noninvasive Electrocardiol 2006;11:306–12.10.1111/j.1542-474X.2006.00122.xSearch in Google Scholar PubMed PubMed Central

[7] Kuppusamy S, Pal GK, Habeebullah S, Ananthanarayanan PH, Pal P. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome. Endocr Res 2015;40:37–43.10.3109/07435800.2014.920350Search in Google Scholar PubMed

[8] Hashim ZH, Hamdan FB, Al-Salihi AR. Autonomic dysfunction in women with polycystic ovary syndrome. Iran J Reprod Med 2015;13:27–34.Search in Google Scholar

[9] Gui J, Wang R-H. Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biomed Online 2017;35:113–20.10.1016/j.rbmo.2017.03.018Search in Google Scholar PubMed

[10] Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Anthropometric and biochemical characteristics of polycystic ovarian syndrome in South Indian women using AES-2006 criteria. Int J Endocrinol Metab 2014;12:e12470.10.5812/ijem.12470Search in Google Scholar PubMed PubMed Central

[11] Sprung VS, Cuthbertson DJ, Pugh CJ, Aziz N, Kemp GJ, Daousi C, et al. Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness. Med Sci Sports Exerc 2013;45:2234–42.10.1249/MSS.0b013e31829ba9a1Search in Google Scholar PubMed

[12] Covington JD, Tam CS, Pasarica M, Redman LM. Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise. Biochimie 2016;124:27–33.10.1016/j.biochi.2014.10.028Search in Google Scholar PubMed PubMed Central

[13] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.10.1016/j.fertnstert.2003.10.004Search in Google Scholar PubMed

[14] World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. 2011;5–7.Search in Google Scholar

[15] Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013;128:873–934.10.1161/CIR.0b013e31829b5b44Search in Google Scholar PubMed

[16] American College of Sports Medicine. ACSM’s Health-Related Physical Fitness Assessment. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 2008:40.Search in Google Scholar

[17] Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354–81.Search in Google Scholar

[18] Hammer Ř, Harper DA, Ryan PD. PAST: Paleontological Statistics software package for education and data analysis. Palaeontol Electron 2001;4:9.Search in Google Scholar

[19] Bissinger A. Cardiac autonomic neuropathy: why should cardiologists care about that? J Diabetes Res 2017;2017:5374176.10.1155/2017/5374176Search in Google Scholar PubMed PubMed Central

[20] Malik M, Camm AJ. Heart rate variability. Clin Cardiol 1990;13:570–6.10.1002/clc.4960130811Search in Google Scholar PubMed

[21] Sá JC, Costa EC, da Silva E, Tamburús NY, Porta A, Medeiros LF, et al. Aerobic exercise improves cardiac autonomic modulation in women with polycystic ovary syndrome. Int J Cardiol 2016;202:356–61.10.1016/j.ijcard.2015.09.031Search in Google Scholar PubMed

[22] Benham JL, Yamamoto JM, Friedenreich CM, Rabi DM, Sigal RJ. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Obes 2018;8:275–84.10.1111/cob.12258Search in Google Scholar PubMed

[23] Michael S, Graham KS, Davis GM. Cardiac autonomic responses during exercise and post-exercise recovery using heart rate variability and systolic time intervals – a review. Front Physiol 2017;8:301.10.3389/fphys.2017.00301Search in Google Scholar PubMed PubMed Central

[24] Kilit C, Paşalı Kilit T. Heart rate variability in normal-weight patients with polycystic ovary syndrome. Anatol J Cardiol 2017;17:404–9.10.14744/AnatolJCardiol.2017.7473Search in Google Scholar PubMed PubMed Central

[25] Di Domenico K, Wiltgen D, Nickel FJ, Magalhães JA, Moraes RS, Spritzer PM. Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter? Fertil Steril 2013;99:286–92.10.1016/j.fertnstert.2012.08.049Search in Google Scholar PubMed

[26] Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF. Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 2009;24:205–17.10.1590/S0102-76382009000200018Search in Google Scholar

[27] Hartikainen JE, Tahvanainen KU, Kuusela TA. Short-term measurement of heart rate variability. In: Malik M, ed. Clinical Guide to Cardiac Autonomic Tests [Internet]. Dordrecht: Springer Netherlands; 1998 [cited 2018 Sep 14]. pp. 149–76. Available from: https://doi.org/10.1007/978-94-017-1057-2_6.10.1007/978-94-017-1057-2_6Search in Google Scholar

[28] Saranya K, Pal GK, Habeebullah S, Pal P. Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2014;40:192–9.10.1111/jog.12154Search in Google Scholar PubMed

[29] Elting MW, Korsen TJ, Schoemaker J. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2001;55:767–76.10.1046/j.1365-2265.2001.01412.xSearch in Google Scholar PubMed

[30] Perciaccante A. Insulin resistance as link between polycystic ovary syndrome and cardiovascular autonomic dysfunction. Int J Cardiol 2009;135:e78–9.10.1016/j.ijcard.2008.04.040Search in Google Scholar PubMed

[31] Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, Asghari-Jafarabadi M, Aliashrafi S, Sadein B. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect 2013;3:206–16.Search in Google Scholar

[32] Yucel A, Noyan V, Sagsoz N. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2006;126:81–6.10.1016/j.ejogrb.2005.11.012Search in Google Scholar PubMed

[33] Özkeçeci G, Ünlü BS, Dursun H, Akçi Ö, Köken G, Onrat E, et al. Heart rate variability and heart rate turbulence in patients with polycystic ovary syndrome. Anatol J Cardiol 2016;16:323–7.10.5152/AnatolJCardiol.2015.6307Search in Google Scholar

[34] Wulsin LR, Horn PS, Perry JL, Massaro JM, D’Agostino RB. Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality. J Clin Endocrinol Metab 2015;100:2443–8.10.1210/jc.2015-1748Search in Google Scholar PubMed

[35] Pei J, Tang W, Li L-X, Su C-Y, Wang T. Heart rate variability predicts mortality in peritoneal dialysis patients. Ren Fail 2015;37:1132–7.10.3109/0886022X.2015.1061729Search in Google Scholar PubMed

[36] Bento L, Fonseca-Pinto R, Póvoa P. Autonomic nervous system monitoring in intensive care as a prognostic tool. Systematic review. Rev Bras Ter Intensiva 2017;29:481–9.10.5935/0103-507X.20170072Search in Google Scholar PubMed PubMed Central

Received: 2018-11-11
Accepted: 2019-03-22
Published Online: 2019-05-16

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Minireview
  2. Glial pathology in neuropsychiatric disorders: a brief review
  3. Original Articles
  4. Fenugreek seed extract ameliorates cognitive deficits in streptozotocin-induced diabetic rats
  5. The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats
  6. Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats
  7. Sexual stimulant effects of the mixture of Mondia whitei, Dracaena arborea, and Bridelia ferruginea in normal and prediabetic male Wistar rats
  8. Evaluating exercise challenge to validate cardiac autonomic dysfunction in lean PCOS phenotype
  9. Involvement of proinflammatory cytokines and metallothionein in the repairing of arsenic-mediated uterine tissue damage by curcumin
  10. Antioxidant potentials and effects on the hematology and osmotic fragility scores of a polyherbal formulation used in Southeast Nigeria
  11. Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model
  12. Phytochemicals and antidiabetic activity of the aqueous extract of the Punica granatum fruit in streptozotocin-induced diabetic mice
  13. Ficus cunia Buch.-Ham. ex Roxb. (leaves): An experimental evaluation of the cytotoxicity, thrombolytic, analgesic and neuropharmacological activities of its methanol extract
  14. Ameliorative effects of Annona muricata Linn. (Annonaceae) against potassium dichromate-induced hypertension in vivo: involvement of Kim-1/p38 MAPK/Nrf2 signaling
  15. Case Report
  16. A rare case of clomiphene-induced leukocytoclastic vasculitis
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2018-0198/html
Scroll to top button